# Vascular Functions in Myeloma Patients During Anti-tumor Therapy

> **NCT03776331** · — · UNKNOWN · sponsor: **University Hospital, Essen** · enrollment: 96 (estimated)

## Conditions studied

- Cardiooncology
- Myeloma
- Endothelial Dysfunction

## Interventions

- **DIAGNOSTIC_TEST:** Flow mediated dilation

## Key facts

- **NCT ID:** NCT03776331
- **Lead sponsor:** University Hospital, Essen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-28
- **Primary completion:** 2019-12-28
- **Final completion:** 2020-03-28
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03776331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03776331, "Vascular Functions in Myeloma Patients During Anti-tumor Therapy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03776331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*